RASSF4/AD037 is a potential Ras Effector/Tumor Suppressor of the RASSF family

K Eckfeld, Luke Hesson, MD Vos, I Bieche, Farida Latif, GJ Clark

    Research output: Contribution to journalArticle

    88 Citations (Scopus)


    Activated Ras proteins interact with a broad range of effector proteins to induce a diverse series of biological consequences. Although typically associated with enhanced growth and transformation, activated Ras may also induce growth antagonistic effects such as senescence or apoptosis. It is now apparent that some of the growth-inhibitory properties of Ras are mediated via the RASSF family of Ras effector/tumor suppressors. To date, four members of this family have been identified (Nore1, RASSF1, RASSF2, and RASSF3). We now identify a fifth member of this group, RASSF4 (AD037). RASSF4 shows approximately 25% identity with RASSF1A and 60% identity with RASSF2. RASSF4 binds directly to activated K-Ras in a GTP-dependent manner via the effector domain, thus exhibiting the basic properties of a Ras effector. Overexpression of RASSF4 induces Ras-dependent apoptosis in 293-T cells and inhibits the growth of human tumor cell lines. Although broadly expressed in normal tissue, RASSF4 is frequently down-regulated by promoter methylation in human tumor cells. Thus, RASSF4 appears to be a new member of the RASSF family of potential Ras effector/tumor suppressors.
    Original languageEnglish
    Pages (from-to)8688-8693
    Number of pages6
    JournalCancer Research
    Publication statusPublished - 1 Jan 2004


    Dive into the research topics of 'RASSF4/AD037 is a potential Ras Effector/Tumor Suppressor of the RASSF family'. Together they form a unique fingerprint.

    Cite this